source
- GSK says UK restructuring will have limited impact on staff, focusing cuts on support rolesGSK executives said the company's global restructuring will only modestly affect UK staff, mainly targeting support functions at headquarters. CEO Luke Miels explained during the Q3 earnings call…
- HHS pauses enforcement of ban on compounding wellness peptides as FDA drafts new rulesHHS announced it will temporarily stop enforcing the existing prohibition on the compounding of certain peptides marketed for wellness. The agency said the move is intended to protect consumer saf…